J. Goldman & CO LP Seelos Therapeutics, Inc. Transaction History

J. Goldman & CO LP

  • $3.27 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.59 - $2.38 $85,860 - $128,520
-54,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$1.69 - $2.89 $3.09 Million - $5.28 Million
-1,828,263 Reduced 97.13%
54,000 $130,000
Q2 2021

Aug 16, 2021
BUY
$2.64 - $6.32 $4.84 Million - $11.6 Million
1,835,013 Added 3883.63%
1,882,263 $4.97 Million
Q1 2021

May 17, 2021
BUY
$1.35 - $4.99 $63,787 - $235,777
47,250 New
47,250 $236,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email